Detalles de la búsqueda
1.
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Nat Immunol
; 21(11): 1346-1358, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32868929
2.
A randomized phase III trial of postoperative surveillance for pathological stage II and IIIA non-small cell lung cancer (JCOG2012, PHOENIX).
Jpn J Clin Oncol
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693750
3.
Rare but clinically important salivary gland-type tumor of the lung: A review.
Jpn J Clin Oncol
; 54(2): 121-128, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952098
4.
Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer.
Jpn J Clin Oncol
; 54(4): 479-488, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183216
5.
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
Int J Clin Oncol
; 29(3): 248-257, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319510
6.
Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks.
Surg Today
; 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430378
7.
Clinicopathological features and prognostic impact of dirty necrosis in metastatic lung cancers from the colon and rectum.
Cancer Sci
; 114(5): 2169-2177, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369892
8.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Lancet
; 399(10335): 1607-1617, 2022 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461558
9.
Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma.
Mod Pathol
; 36(9): 100209, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149221
10.
The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lung.
Pathol Int
; 73(10): 497-508, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589431
11.
Tumor size exceeding 5 cm as a valid prognostic factor in all stages of thymic epithelial tumors.
Surg Today
; 53(1): 42-50, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908101
12.
18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.
Cancer Sci
; 113(4): 1488-1496, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023268
13.
Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.
Cancer Sci
; 113(4): 1497-1506, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35181964
14.
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer.
Jpn J Clin Oncol
; 52(4): 383-387, 2022 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34999817
15.
The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303.
Surg Today
; 52(10): 1463-1471, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211804
16.
Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
Ann Surg Oncol
; 28(12): 7219-7227, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33900499
17.
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study).
Jpn J Clin Oncol
; 51(8): 1330-1333, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34021345
18.
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer.
Jpn J Clin Oncol
; 51(1): 28-36, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147608
19.
Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer.
Jpn J Clin Oncol
; 51(3): 333-344, 2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506253
20.
Correlation between the number of viable tumor cells and immune cells in the tumor microenvironment in non-small cell lung cancer after induction therapy.
Pathol Int
; 71(8): 512-520, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34115921